surmount trials tirzepatide ESC 2025: post-hoc SURMOUNT-5 data affirms tirzepatide's lead in CVD risk reduction SURMOUNT-1 (NEJM 2022) tested tirzepatide

And its not something you can manufacture by willpower alone. The clinicians we spoke with unanimously agree that GLP-1s generally should be taken for life

Additional measures to avoid oral complications should also be taken, according to Sachar

Clinical trials show that 3050% of people who maintain consistent lifestyle changes keep most or all of their weight off after stopping GLP-1 therapy

On the other hand, if employers that already cover Zepbound move to Employer Connect, Lilly may take a pricing hit

Semaglutide can be especially appealing for busy professionals, parents, and midlife adults who need a plan that fits real life rather than an all-or-nothing approach